INternational Soft Tissue saRcoma ConsorTium (INSTRuCT) consensus statement: Imaging recommendations for the management of rhabdomyosarcoma.

Autor: Schoot RA; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: R.A.Schoot-3@prinsesmaximacentrum.nl., van Ewijk R; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: R.vanEwijk-2@prinsesmaximacentrum.nl., von Witzleben AA; Institute of Radiology Olgahospital, Zentrum für Kinder-, Jugend- und Frauenmedizin, Klinikum Stuttgart, Stuttgart, Germany. Electronic address: a.witzleben@klinikum-stuttgart.de., Kao SC; Department of Radiology, The University of Iowa Carver College of Medicine, Iowa City, IA, USA. Electronic address: simon-kao@uiowa.edu., Merks JHMH; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: j.h.m.merks@prinsesmaximacentrum.nl., Morosi C; Department of Radiology, Istituto Nazionale Tumori, Milan, Italy. Electronic address: Carlo.Morosi@istitutotumori.mi.it., Pace E; Department of Radiology, The Royal Marsden NHS Foundation Trust, London, England, United Kingdom. Electronic address: Erika.Pace@rmh.nhs.uk., Shulkin BL; Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, TN, USA. Electronic address: Barry.shulkin@stjude.org., Ferrari A; Pediatric Oncology Unit, Medical Oncology and Hematology Department, Istituto Nazionale Tumori, Milan, Italy. Electronic address: Andrea.Ferrari@istitutotumori.mi.it., von Kalle T; Institute of Radiology Olgahospital, Zentrum für Kinder-, Jugend- und Frauenmedizin, Klinikum Stuttgart, Stuttgart, Germany. Electronic address: T.vonKalle@klinikum-stuttgart.de., van Rijn RR; Department of Radiology and Nuclear Medicine, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: r.r.vanrijn@amsterdamumc.nl., Weiss AR; Department of Pediatrics, Division of Pediatric Hematology-Oncology, Maine Medical Center, Portland, ME, USA. Electronic address: Aaron.Weiss@mainehealth.org., Sparber-Sauer M; Klinikum der Landeshauptstadt Stuttgart gKAöR, Olgahospital, Stuttgart Cancer Center, Zentrum für Kinder-, Jugend- und Frauenmedizin, Pädiatrie 5 (Pädiatrische Onkologie, Hämatologie, Immunologie), Stuttgart, Germany; University of Medicine Tübingen, Tübingen, Germany. Electronic address: m.sparber@klinikum-stuttgart.de., Ter Horst SAJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Radiology and Nuclear Medicine, Wilhelmina Children's Hospital/University Medical Centre Utrecht, Utrecht, the Netherlands. Electronic address: S.A.J.terHorst-3@umcutrecht.nl., McCarville MB; Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, TN, USA. Electronic address: Beth.mccarville@stjude.org.
Jazyk: angličtina
Zdroj: European journal of radiology [Eur J Radiol] 2023 Sep; Vol. 166, pp. 111012. Date of Electronic Publication: 2023 Jul 25.
DOI: 10.1016/j.ejrad.2023.111012
Abstrakt: Rhabdomyosarcoma is the most common soft-tissue neoplasm in the pediatric population. The survival of children with rhabdomyosarcoma has only marginally improved over the past 25 years and remains poor for those with metastatic disease. A significant challenge to advances in treatment of rhabdomyosarcoma is the relative rarity of this disease, necessitating years to complete clinical trials. Progress can be accelerated by international cooperation and sharing national experiences. This necessitates agreement on a common language to describe patient cohorts and consensus standards to guide diagnosis, treatment, and response assessment. These goals formed the premise for creating the INternational Soft Tissue saRcoma ConsorTium (INSTRuCT) in 2017. Multidisciplinary members of this consortium have since developed international consensus statements on the diagnosis, treatment, and management of pediatric soft-tissue sarcomas. Herein, members of the INSTRuCT Diagnostic Imaging Working Group present international consensus recommendations for imaging of patients with rhabdomyosarcoma at diagnosis, at staging, and during and after completion of therapy. The intent is to promote a standardized imaging approach to pediatric patients with this malignancy to create more-reliable comparisons of results of clinical trials internationally, thereby accelerating progress in managing rhabdomyosarcoma and improving survival.
Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2023 Elsevier B.V. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: